Related Experiment Video

Updated: May 17, 2026

Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain
08:48

Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain

Published on: October 25, 2016

Characterization of T-cell receptors directed against HLA-A*01-restricted and C*07-restricted epitopes of MAGE-A3 and

Shigui Zhu1, Benoit J Van den Eynde, Pierre G Coulie

  • 1Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Journal of Immunotherapy (Hagerstown, Md. : 1997)
|October 24, 2012
PubMed

Insights

Genetically engineered T-cell receptors (TCRs) targeting tumor antigens show promise in cancer therapy. New TCRs targeting MAGE-A3 and MAGE-A12 expand potential applications for adoptive immunotherapy in melanoma patients.

Area of Science:

  • Immunology
  • Oncology
  • Genetics

Background:

  • T-cell receptor (TCR) engineered T cells have shown efficacy in clinical trials for tumor regression.
  • Current TCR therapies predominantly target HLA-A*0201, limiting application in diverse patient populations.
  • HLA class I alleles like HLA-C*07 and HLA-A*01 are prevalent in Caucasian melanoma patients, offering opportunities for broader therapeutic reach.

Purpose of the Study:

  • To isolate and characterize novel T-cell receptors (TCRs) targeting MAGE-A3 and MAGE-A12 antigens.
  • To evaluate the efficacy of these TCRs in the context of HLA-A*01 and HLA-C*07 alleles.
  • To identify superior TCR candidates for adoptive immunotherapy trials.

Main Methods:

  • Isolation of tumor-reactive T-cell clones.
  • Cloning of TCRs into a recombinant retroviral expression vector.
  • Comparative analysis of TCRs for their ability to confer antigen recognition on peripheral blood mononuclear cells.

Main Results:

  • Two TCRs targeting MAGE-A12 (HLA-C*07) and two TCRs targeting MAGE-A3 (HLA-A*01) were successfully cloned.
  • One MAGE-A3-reactive TCR and one MAGE-A12-reactive TCR demonstrated superior performance.
  • The selected TCRs effectively enabled transduced cells to recognize a broad range of antigen and MHC-positive target cells.

Conclusions:

  • The identified TCRs are promising candidates for adoptive immunotherapy in cancer treatment.
  • These TCRs can potentially broaden the applicability of TCR-based therapies to patients with specific HLA types.
  • Further clinical investigation of these novel TCRs is warranted for melanoma treatment.

More Related Videos

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

Identification of Rare Antigen-Specific T Cells from Mouse Lungs with Peptide:Major Histocompatibility Complex Tetramers09:15

Identification of Rare Antigen-Specific T Cells from Mouse Lungs with Peptide:Major Histocompatibility Complex Tetramers

Published on: July 19, 2024

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...